Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/175/31/23

Funding

  • National Inst of Allergy & Infectious Di: $6,014,180.00